Topics

Articles

The Vicenza site will run about 54,000 square feet in size. 

Value is attributed to the rise in counterfeit cases and ongoing regulations surrounding anti-counterfeit packaging. 

CDMO’s goal is to increase building’s aseptic manufacturing capacity. 

Acquisition helps expand pharma marketing reach and opens door for growth opportunities.

The conference will focus on the full breadth of commercialization strategies and operations. 

Acquisition includes company’s inflammatory disease medicines.

Purchase allows company to provide a fully integrated small-to-medium scale sterile injectable service offering for the biopharma industry.

The newly established business under Advent International and Warburg Pincus will be named Simtra BioPharma Solutions.

Deal—expected to be finalized by the end of the year—grows the logistics provider’s healthcare capabilities.  

Manufacturing capacity of company’s High Point facility now doubles as a result. 